Acepodia Signs Strategic Clinical Partnership with Pfizer for Autoimmune Diseases
Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.
Bioorthogonal Chemistry | 04/09/2024 | By Aishwarya | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy